Presentation: Development and Application in the use of NAMs for Next Generation Risk Assessment – Learnings from Industry case studies

This talk provides an update on exposure led NGRA risk assessment case studies focusing on the types of data generated and how they can be integrated in a tiered manner. Further highlighted are areas where additional ongoing research is taking place on aspects impacting the bioactivity exposure ratio and ongoing benchmarking case studies to build understanding of how protective are the approaches to address barriers to regulatory adoption and acceptance.

View the presentation here.


Comments are closed.